The Bird Foundation (Israel-U.S. Binational Industrial Research and Development) approved a $10 million investment in 11 joint US-Israeli development projects, the fund said Sunday.
The investment spans the life sciences, communications, homeland security and alternative energy industries, linking Israeli companies with US partners in those sectors. Participants in the projects include established companies such as M-Systems, Spansion and Ibasis, as well as start-ups Rosetta Genomics, GreenFuel Technologies, Enforsys, GlobalSim and Chromadex, covering research from the development of a liver cancer drug, to a project aimed at producing biofuel from algae, and capturing CO2 emissions from coal power plants.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>